Young-onset Parkinson's disease: Hospital utilization and medical comorbidity in a nationwide survey

Neuroepidemiology

Volumn 29, Issue 1-2, 2007, Pages 39-43

  Louis, Elan D ^a,b,d   Henchcliffe, Claire ^c   Bateman, Brian T ^b   Schumacher, Christian ^b  

^a Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^b Cornell University ^*  (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d NEUROLOGICAL INSTITUTE   (United States)

Author keywords

Comorbidity; Hospital utilization; Parkinson's disease, epidemiology; Psychosis

Indexed keywords

ADULT; ARTICLE; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HEALTH CARE UTILIZATION; HEALTH SURVEY; HIP FRACTURE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL UTILIZATION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PELVIS FRACTURE; PNEUMONIA; PSYCHOSIS;

ADOLESCENT; ADULT; AGE OF ONSET; CASE-CONTROL STUDIES; DIAGNOSIS-RELATED GROUPS; FEMALE; HEALTH CARE SURVEYS; HEALTH STATUS; HOSPITALIZATION; HUMANS; MALE; PARKINSON DISEASE; TREATMENT OUTCOME;

EID: 36649002637     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000108916     Document Type: Article

References (17)

1. Dodel RC, Eggert KM, Singer MS, Eichhorn TE, Pogarell O, Oertel WH: Costs of drug treatment in Parkinson's disease. Mov Disord 1998;13:249-254.
2. Chrischilles EA, Rubenstein LM, Voelker MD, Wallace RB, Rodnitzsky RL: The health burdens of Parkinson's disease. Mov Disord 199813:406-413.
3. Whetten-Goldstein K, Sloan F, Kulas E, Cutson T, Schenkman M: The burden of Parkinson's disease on society, family, and the individual. J Am Geriatr Soc 1997;45:844-849.
4. Guttman M, Slaughter PM, Theriault M-E, DeBoer DP, Naylor CD: Parkinsonism in Ontario: physician utilization. Can J Neurol Sci 2002;29:221-226.
5. Pressley JC, Louis ED, Tang M-X, Cote L, Cohen PD, Glied S, Mayeux R: The impact of comorbid disease and injuries on resource use and expenditures in parkinsonism. Neurology 2003;60:87-93.
6. Guttman M, Slaughter PM, Theriault M-E, DeBoer DP, Naylor CD: Burden of Parkinson's disease: a population-based study. Mov Disord 2003;18:313-319.
7. Guttman M, Slaughter PM, Theriault M-E, DeBoer DP, Naylor CD: Parkinsonism in Ontario: comorbidity associated with hospitalization in a large cohort. Mov Disord 2004;19:49-53.
8. Cubo E, Alvarez E, Morant C, et al: Burden of disease related to Parkinson's disease in Spain in the year 2000. Mov Disord 2005;20:1481-1487.
9. Huse DM, Schulman K, Orsini L, Castelli-Haley J, Kennedy S, Lenhart G: Burden of illness in Parkinson's disease. Mov Disord 2005;20:1449-1454.
10. Leibson CL, Maraganore DM, Bower JH, Ransom JE, O'Brien PC, Rocca WA: Comorbid conditions associated with Parkinson's disease: a population-based study. Mov Disord 2006;21:446-455.
11. Noyes K, Liu H, Li Y, Holloway R, Dick AW: Economic burden associated with Parkinson's disease on elderly Medicare beneficiaries. Mov Disord 2006;21:362-372.
12. Golbe LI: Young-onset Parkinson's disease: a clinical review. Neurology 1991;41:168-173.
13. Schrag A, Ben-Shlomo Y, Brown R, Marsden CD, Quinn N: Young-onset Parkinson's disease revisited - Clinical features, natural history, and mortality. Mov Disord 1998;13:885-894.
14. Hervey SL, Purves HR, Guller U, Toth AP, Vail TP, Pietrobon R: Provider volume of total knee arthroplasties and patient outcomes in the HCUP-Nationwide Inpatient Sample. J Bone Joint Surg Am 2003;85:1775-1783.
15. Dubinksy RM: No going home for hospitalized Huntington's disease patients. Mov Disord 2005;10:1316-1322.
16. Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-383.
17. Goldstein LB, Samsa GP, Matchar DB, Horner RD: Charlson index of comorbidity adjustment for ischemic stroke outcome studies. Stroke 2004;35:1941-1945.